Clinical Trials Browser

Has results × Oligodendroglioma × Imatinib Mesylate × Clear all

NCT00049127 2019-10-21

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Phase 1/2 Completed

64 enrolled 11 charts

Brain Neoplasms, Glioma, Oligodendroglioma